Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1/2 1

Status

Completed 23Terminated 6Recruiting 5Active not recruiting 5Unknown 2Withdrawn 1Available 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 20Thoracic 5Breast 5Gastrointestinal 4CNS 4Sarcoma 2Head & Neck 1Gynecologic 1Endocrine 1Dermatologic 1

Conditions

Sarcoma 1Gastrointestinal Stromal Tumors 1

Interventions

Doxorubicin 25Radiotherapy 16apatinib 15Cyclophosphamide 15Ifosfamide 13anlotinib 12camrelizumab 10Temozolomide 9Imatinib Mesylate 9Vincristine 8Surgical Procedures, Operative 7Neoadjuvant Therapy 7Methotrexate 7Drug Therapy 7Dactinomycin 5Blood Specimen Collection 5fludarabine phosphate 4Paclitaxel 4Immune Checkpoint Inhibitors 4Etoposide 4Docetaxel 4Carboplatin 4toripalimab 3pembrolizumab 3Trabectedin 3Topotecan 3Surveys and Questionnaires 3Radiation Dose Hypofractionation 3Nivolumab 3Melphalan 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Sunitinib × Sarcoma × Clear all
NCT03862768 2019-03-05

Role of Surgery in Patients With Focally Progressive Gastrointestinal Stromal Tumors (GISTs) After Imatinib Treatment

Shanghai Zhongshan Hospital

Phase NA Unknown
92 enrolled
GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT00753727 2011-06-23

SUNXRT

Australasian Sarcoma Study Group

Phase 1/2 Unknown
26 enrolled
Sarcoma

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡